116 related articles for article (PubMed ID: 20817753)
21. Base substitutions at scissile bond sites are sufficient to alter RNA-binding and cleavage activity of RNase III.
Kim K; Sim SH; Jeon CO; Lee Y; Lee K
FEMS Microbiol Lett; 2011 Feb; 315(1):30-7. PubMed ID: 21133991
[TBL] [Abstract][Full Text] [Related]
22. Peptide-oligonucleotide conjugates form stable and selective complexes with antibody and DNA.
Tennilä T; Antopolsky M; Azhayev A; Azhayeva E
Bioconjug Chem; 2008 Jul; 19(7):1361-7. PubMed ID: 18529023
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.
Geller BL; Deere JD; Stein DA; Kroeker AD; Moulton HM; Iversen PL
Antimicrob Agents Chemother; 2003 Oct; 47(10):3233-9. PubMed ID: 14506035
[TBL] [Abstract][Full Text] [Related]
24. Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics.
Arora V; Devi GR; Iversen PL
Curr Pharm Biotechnol; 2004 Oct; 5(5):431-9. PubMed ID: 15544491
[TBL] [Abstract][Full Text] [Related]
25. Induced-fit recognition of DNA by small circular oligonucleotides.
Escaja N; Gómez-Pinto I; Viladoms J; Rico M; Pedroso E; González C
Chemistry; 2006 May; 12(15):4035-42. PubMed ID: 16607659
[TBL] [Abstract][Full Text] [Related]
26. Efficient sequence-specific cleavage of RNA using novel europium complexes conjugated to oligonucleotides.
Hall J; Hüsken D; Pieles U; Moser HE; Häner R
Chem Biol; 1994 Nov; 1(3):185-90. PubMed ID: 9383388
[TBL] [Abstract][Full Text] [Related]
27. Mismatch formation in solution and on DNA microarrays: how modified nucleosides can overcome shortcomings of imperfect hybridization caused by oligonucleotide composition and base pairing.
Seela F; Budow S
Mol Biosyst; 2008 Mar; 4(3):232-45. PubMed ID: 18437266
[TBL] [Abstract][Full Text] [Related]
28. Stereospecificity of oligonucleotide interactions revisited: no evidence for heterochiral hybridization and ribozyme/DNAzyme activity.
Hoehlig K; Bethge L; Klussmann S
PLoS One; 2015; 10(2):e0115328. PubMed ID: 25679211
[TBL] [Abstract][Full Text] [Related]
29. Rapid selection of accessible and cleavable sites in RNA by Escherichia coli RNase P and random external guide sequences.
Lundblad EW; Xiao G; Ko JH; Altman S
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2354-7. PubMed ID: 18263737
[TBL] [Abstract][Full Text] [Related]
30. Regulation of ribozyme activity with short oligonucleotides.
Komatsu Y
Biol Pharm Bull; 2004 Apr; 27(4):457-62. PubMed ID: 15056847
[TBL] [Abstract][Full Text] [Related]
31. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
[TBL] [Abstract][Full Text] [Related]
32. Antisense masking reveals contributions of mRNA-rRNA base pairing to translation of Gtx and FGF2 mRNAs.
Panopoulos P; Mauro VP
J Biol Chem; 2008 Nov; 283(48):33087-93. PubMed ID: 18832380
[TBL] [Abstract][Full Text] [Related]
33. Catalytic cleavage of an RNA target by 2-5A antisense and RNase L.
Maitra RK; Li G; Xiao W; Dong B; Torrence PF; Silverman RH
J Biol Chem; 1995 Jun; 270(25):15071-5. PubMed ID: 7797490
[TBL] [Abstract][Full Text] [Related]
34. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
[TBL] [Abstract][Full Text] [Related]
35. An RNA external guide sequence ribozyme targeting human interleukin-4 receptor alpha mRNA.
Dreyfus DH; Matczuk A; Fuleihan R
Int Immunopharmacol; 2004 Aug; 4(8):1015-27. PubMed ID: 15222976
[TBL] [Abstract][Full Text] [Related]
36. Directing RNase P-mediated cleavage of target mRNAs by engineered external guide sequences in cultured cells.
Jiang X; Sunkara N; Lu S; Liu F
Methods Mol Biol; 2014; 1103():45-56. PubMed ID: 24318885
[TBL] [Abstract][Full Text] [Related]
37. Detection of unique Ebola virus oligonucleotides using fluorescently-labeled phosphorodiamidate morpholino oligonucleotide probe pairs.
Xiong Y; McQuistan TJ; Stanek JW; Summerton JE; Mata JE; Squier TC
Anal Biochem; 2018 Sep; 557():84-90. PubMed ID: 30030994
[TBL] [Abstract][Full Text] [Related]
38. Oligonucleotides with Cationic Backbone and Their Hybridization with DNA: Interplay of Base Pairing and Electrostatic Attraction.
Schmidtgall B; Kuepper A; Meng M; Grossmann TN; Ducho C
Chemistry; 2018 Feb; 24(7):1544-1553. PubMed ID: 29048135
[TBL] [Abstract][Full Text] [Related]
39. Facilitator oligonucleotides increase ribozyme RNA binding to full-length RNA substrates in vitro.
Denman RB
FEBS Lett; 1996 Mar; 382(1-2):116-20. PubMed ID: 8612731
[TBL] [Abstract][Full Text] [Related]
40. Re-Engineering RNA Molecules into Therapeutic Agents.
Egli M; Manoharan M
Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
